Evidence map›Paper›PMID 40645927›Full record

ArticleNature communications2025

Translating microbial kinetics into quantitative responses and testable hypotheses using Kinbiont.

Fabrizio Angaroni, Alberto Peruzzi, Edgar Z Alvarenga, Fernanda Pinheiro

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fabrizio AngaroniComputational Biology Research Centre, Human Technopole, Milan, Italy.
Alberto PeruzziComputational Biology Research Centre, Human Technopole, Milan, Italy.
Edgar Z AlvarengaFuzuê Tech, Kraków, Poland.
Fernanda PinheiroComputational Biology Research Centre, Human Technopole, Milan, Italy. fernanda.pinheiro@fht.org.ORCID http://orcid.org/0000-0002-0132-0562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Challenges such as antibiotic resistance, ecosystem resilience, and bioproduction optimization require quantitative methods to characterize microbial responses to environmental perturbations. However, translating rapidly growing microbial growth datasets into actionable insights remains challenging. To address this issue, we introduce Kinbiont-an open-source tool that integrates dynamic models with machine learning methods for data-driven discovery in microbiology. Kinbiont consists of three sequential yet independent modules: (1) data preprocessing, (2) model-based parameter inference with both user-defined differential equation systems and hard-coded growth models, and (3) explainable machine learning analyses to map experimental conditions directly to inferred biological parameters. We benchmark Kinbiont using various microbial growth datasets, including diauxic curves, ethanol bioproduction, and phage-bacteria interactions. To illustrate Kinbiont's ability to automatically identify mathematical relationships underlying microbial responses, we revisit Monod's classical nutrient-limitation experiment and perform a growth inhibition assay using a ribosome-targeting antibiotic. In a large-scale ecotoxicological screen, Kinbiont reveals growth-phase-specific sensitivities to environmental stressors. Together, these results demonstrate how Kinbiont converts microbial kinetics data into interpretable and testable hypotheses, acting as a powerful tool to accelerate discovery in modern microbiology.

Indexed as

BacteriaAnti-Bacterial AgentsEthanolKineticsMachine LearningModels, BiologicalAnti-Bacterial AgentsEthanol

Identifiers

PMID40645927
PMCPMC12254256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.